GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference

Trending Topics in Gastroenterology

Explore current gastroenterology questions, clinical answers, and emerging research by topic.

31

Fatty Pancreas in MASLD: JGH | March 2026

Introduction Metabolic dysfunction-associated steatotic liver disease is now recognized as a multisystem metabolic disorder affecting not only the liver but also cardiovascular, renal, and endocrine systems. Parallel to...

32

Tirzepatide and Acute Pancreatitis: Pancreatology | March 2026

Introduction With the rapid rise of obesity and type 2 diabetes, incretin-based therapies such as Tirzepatide have transformed metabolic care. These agents offer substantial benefits in weight reduction...

33

Peripancreatic Vascular Involvement in AIP: CGH | March 2026

Introduction Autoimmune pancreatitis (AIP) is a unique IgG4-related inflammatory disease with generally favourable outcomes following glucocorticoid therapy. However, beyond pancreatic inflammation, extension into the peripancreatic vasculature can occur,...

34

NAPAN Trial in Metastatic Pancreatic Cancer: EJC/ March 2026

Introduction: Metastatic pancreatic cancer continues to carry a dismal prognosis, with limited effective options after failure of first-line gemcitabine-based therapy. Liposomal irinotecan (nal-IRI) combined with 5-fluorouracil/leucovorin (5-FU/LV) is...

35

GOLP in High-Risk Resectable Intrahepatic Cholangiocarcinoma NEJM, March 2026

Introduction Intrahepatic cholangiocarcinoma (iCCA) is the second most common primary liver cancer and carries a poor prognosis even after curative surgery. Recurrence rates exceed 50%, particularly in patients...

36

Glucose Addiction in Cholangiocarcinoma: Hepatoma Research, 2025

Introduction Cholangiocarcinoma (CCA) is the second most common primary liver cancer and is associated with poor prognosis due to late diagnosis and aggressive tumour biology. Increasing evidence links...

37

Acute Pancreatitis to Pancreatic Damage and Diabetes: Gastroenterology | March 2026

Introduction Acute pancreatitis (AP) is often considered a self-limited illness once the acute episode resolves, with survival exceeding 95%. However, increasing evidence suggests that AP frequently initiates a...

38

Metabolic Syndrome Increases Cholangiocarcinoma Risk- Hepatology Feb.26

This large population-based cohort study evaluated the relationship between metabolic syndrome (MetS) and the risk of cholangiocarcinoma (CCA), including both intrahepatic and extrahepatic subtypes. The study included nearly...

39

Blood-Based Early Detection for Pancreatic Cancer: Are We There Yet- Gastroenterology Feb.26

Introduction Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest cancers, largely because it is usually diagnosed late. Individuals with familial risk, pathogenic germline variants, or pancreatic cystic...

40

NLR and Acute Pancreaatitis - Front Med 2026

Overview The neutrophil-to-lymphocyte ratio (NLR) is a simple, cost-effective biomarker derived from routine blood tests. It measures the ratio of neutrophils (a type of white blood cell involved...

Previous
1234567
Next
GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer